Literature DB >> 3190959

Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.

G Hausdorf1, G Morf, G Beron, R Erttmann, K Winkler, G Landbeck, E W Keck.   

Abstract

Cardiac performance was evaluated at least two years after doxorubicin treatment in childhood in 55 patients without overt congestive cardiomyopathy. None of the patients had received mediastinal irradiation. Computer-assisted analysis of digitised echocardiograms showed impaired rapid diastolic filling and an increased change of dimension between minimal cavity dimension and mitral valve opening. This impairment of diastolic function was related to the cumulative dose of doxorubicin. In contrast when angiotensin II was infused to increase the afterload the end systolic pressure-length and stress-shortening relation indicated normal left ventricular systolic function. But during baseline conditions the end systolic wall stress was significantly increased in patients in whom the cumulative dose of doxorubicin exceeded 360 mg/m2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190959      PMCID: PMC1216578          DOI: 10.1136/hrt.60.4.309

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  30 in total

1.  Combined hemodynamic-ultrasonic method for studying left ventricular wall stress: comparison with angiography.

Authors:  B R Brodie; L P McLaurin; W Grossman
Journal:  Am J Cardiol       Date:  1976-05       Impact factor: 2.778

Review 2.  Age-related adriamycin cardiotoxicity in children.

Authors:  C B Pratt; J L Ransom; W E Evans
Journal:  Cancer Treat Rep       Date:  1978-09

3.  Non-invasive assessment of end-systolic pressure-length and stress-shortening relationships in normal individuals: significance of different loading conditions induced by methoxamine and angiotensin II.

Authors:  G Hausdorf; J Gluth; C A Nienaber
Journal:  Eur Heart J       Date:  1987-10       Impact factor: 29.983

4.  Determination of systemic vascular resistance by a noninvasive technic.

Authors:  M A Stefadouros; M J Dougherty; W Grossman; E Craige
Journal:  Circulation       Date:  1973-01       Impact factor: 29.690

5.  [Abnormal left-ventricular contraction and filling in patients receiving adriamycin for solid tumours (author's transl)].

Authors:  E Stein; P Hanrath; W Bleifeld; M Garbrecht; U Müllerleile
Journal:  Dtsch Med Wochenschr       Date:  1978-09-08       Impact factor: 0.628

6.  The study of left ventricular function from digitized echocardiograms.

Authors:  M T Upton; D G Gibson
Journal:  Prog Cardiovasc Dis       Date:  1978 Mar-Apr       Impact factor: 8.194

7.  End-systolic pressure/volume ratio: a new index of ventricular contractility.

Authors:  K Sagawa; H Suga; A A Shoukas; K M Bakalar
Journal:  Am J Cardiol       Date:  1977-11       Impact factor: 2.778

8.  Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization.

Authors:  M R Bristow; J W Mason; M E Billingham; J R Daniels
Journal:  Ann Intern Med       Date:  1978-02       Impact factor: 25.391

9.  Anthracycline cardiomyopathy monitored by morphologic changes.

Authors:  M E Billingham; J W Mason; M R Bristow; J R Daniels
Journal:  Cancer Treat Rep       Date:  1978-06

10.  Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy.

Authors:  J W Mason; M R Bristow; M E Billingham; J R Daniels
Journal:  Cancer Treat Rep       Date:  1978-06
View more
  10 in total

Review 1.  Childhood cancer: cure at what cost?

Authors:  P H Morris-Jones; A W Craft
Journal:  Arch Dis Child       Date:  1990-06       Impact factor: 3.791

2.  Tei index in adult patients submitted to adriamycin chemotherapy: failure to predict early systolic dysfunction. Diagnosis of adriamycin cardiotoxicity.

Authors:  Luis E Rohde; Alexandre Baldi; Cristiane Weber; Guilherme Geib; Nicolle Gollo Mazzotti; Marlon Fiorentini; Murilo Roggia; Rodrigo Pereira; Nadine Clausell
Journal:  Int J Cardiovasc Imaging       Date:  2006-09-14       Impact factor: 2.357

Review 3.  Anthracyclines: cardiotoxicity and its prevention.

Authors:  J P Hale; I J Lewis
Journal:  Arch Dis Child       Date:  1994-11       Impact factor: 3.791

4.  Effects of low-dose dobutamine on left ventricular diastolic filling in children.

Authors:  K Harada; M Tamura; T Ito; T Suzuki; G Takada
Journal:  Pediatr Cardiol       Date:  1996 Jul-Aug       Impact factor: 1.655

Review 5.  Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.

Authors:  Diana Iarussi; Paolo Indolfi; Fiorina Casale; Vincenzo Martino; Maria Teresa Di Tullio; Raffaele Calabrò
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

6.  Late effects of anthracycline therapy in childhood in relation to the function of the heart at rest and under physical stress.

Authors:  D Lang; F Hilger; J Binswanger; G Andelfinger; W Hartmann
Journal:  Eur J Pediatr       Date:  1995-05       Impact factor: 3.183

7.  Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography.

Authors:  Timothy C Tan; Marielle Scherrer-Crosbie
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-12-01

8.  Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology.

Authors:  F A Bu'Lock; M G Mott; A Oakhill; R P Martin
Journal:  Br Heart J       Date:  1995-04

9.  Early detection of doxorubicin and daunorubicin cardiotoxicity by echocardiography: diastolic versus systolic parameters.

Authors:  K Schmitt; G Tulzer; M Merl; G Aichhorn; A Grillenberger; G Wiesinger; G Hofstadler
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

10.  Cardiac complications of chemotherapy: role of imaging.

Authors:  Timothy C Tan; Marielle Scherrer-Crosbie
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.